Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.11, moving +1.63% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.11%.

Every time you type a web address into your browser, a quiet transaction happens before the page ever loads. Your device asks ...

How doors, keys, and backtracking unlocked survival horror.

Director Scott Glosserman and writer David J. Stieve chat with IndieWire about reviving their beloved horror film with the ...

The software-as-a-service (SaaS) sell-off or SaaS-pocalypse, as it’s commonly referred to, has been a major story this year.

CoinDesk Research maps five crypto privacy approaches and examines which models hold up as AI improves. Full coverage of ...

While millennials dissect every feeling in £80 therapy sessions, their grandparents built the exact same coping mechanisms ...

Relying on one giant AI model for everything is a trap; it’s too expensive and slow for simple tasks and too risky for the hard stuff when things go wrong.

SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal footing, regardless of size. That equal-weight structure separates it from ...